1 / 6

Herpes Simplex Virus Infections Therapeutic Pipeline Projects Vast Growth Ahead

Herpes Simplex Virus Infections Therapeutic Pipeline Report Provides a Comprehensive Understanding of the Pipeline Activities Covering All Drug Candidates Under Various Stages of Development

NidhiNehani
Télécharger la présentation

Herpes Simplex Virus Infections Therapeutic Pipeline Projects Vast Growth Ahead

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Herpes simplex virus infections Therapeutic Pipeline Projects Vast Growth Ahead

  2. Herpes Simplex Virus (HSV) Infections According to a new research report “Herpes simplex virus infections Therapeutic Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments” published by P&S Market Research, Herpes simplex virus infections Therapeutic pipeline currently exhibits a pipeline with 20 drug candidates. Access More About This Research at: https://www.psmarketresearch.com/market-analysis/hsv-infections-therapeutics-pipeline-analysis Herpes simplex virus infections Therapeutic pipeline in 2017 The study analysed that the Herpes simplex virus infections pipeline comprises of 20 drug candidates in different stages of development.

  3. Herpes Simplex Virus (HSV) Infections Insights on pipeline segments As per the findings of the research, most of the drug candidates are being developed to be administered by oral route. New innovating technologies offer development of promising drugs Many technologies are being developed that offer promising innovative treatments which can control the progression of Herpes simplex virus infections. The technologies include, but not limited to, Vector based technology platform, AdenoVerse technology platform, Juvari’s technology platform and Nanostat technology platform.

  4. Herpes Simplex Virus (HSV) Infections Major companies collaborate for the development of Herpes simplex virus infections Pipeline The research found that various companies have collaborated for the development of Herpes simplex virus infections pipeline. In June 2014, PaxVax Inc., entered into a research and development collaboration with the University of California to develop a combination vaccine to prevent genital herpes simplex virus infections. Some of the key players developing drugs for the treatment of Herpes virus simplex infections include Maruho Co., Ltd., NanoBio Corporation, Lumavita AG and others.

  5. Herpes Simplex Virus (HSV) Infections Download report sample at: https://www.psmarketresearch.com/market-analysis/hsv-infections-therapeutics-pipeline-analysis/report-sample

  6. GET IN TOUCH THANK YOU! For information regarding permissions and other queries Kindly write to: US/Canada Toll-Free: 1-888-778-7886

More Related